Home > Events > Meet veristat at scope europe 2026

1 min read

Meet Veristat at SCOPE Europe 2026

Where Clinical Trial Strategy Meets Smarter Execution

SCOPE Europe: October 13-14, 2026 – Barcelona, Spain

Veristat is pleased to attend SCOPE Europe 2026, bringing together clinical research leaders to explore the strategies, technologies, and approaches shaping clinical trials today. From trial design and clinical operations to patient engagement, data strategy, and emerging technologies, SCOPE Europe creates an important forum for addressing the challenges affecting how studies are planned and delivered.

We’re looking forward to connecting with clinical development leaders in Barcelona to discuss how stronger decisions across a program can lead to more efficient, effective trials. Veristat combines clinical operations, biometrics, regulatory strategy, and medical writing expertise to help sponsors anticipate challenges, navigate complexity, and keep development moving toward regulatory and patient milestones.

Meet with Us

Connect with us at the event to explore how Veristat’s scientific leadership and focused capabilities can help advance your clinical and regulatory milestones.

Kim Boerike, Chief Operating Officer
Balma Gil, Business Development Director
Mohcine Benbijja, Senior Regulatory Affairs Manager 

Schedule a Meeting in Advance
Complete the form on this page to reserve time with our team. We welcome the opportunity to learn about your upcoming programs and explore how Veristat can support your development strategy. 

Our Expertise
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:

  • Clinical Operations Excellence
  • Global Regulatory Strategy & Submissions
  • Full-Service Clinical Development Solutions

If you’ll be at the meeting, let’s make time to discuss how we can help move your programs forward.

 

Share This Event:

   

8 min read

Monthly FDA Guidance and Regulatory News Review - August 2026

This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...

8 min read

Monthly FDA Guidance and Regulatory News Review - July 2026

This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...